Nanoemulsion system for transdermal delivery of tamoxifen citrate: Design, Characterization, effect of penetration enhancers and in vivo studies

Digest Journal of Nanomaterials and Biostructures

Volumn 7, Issue 4, 2012, Pages 1373-1387

  Pathan, Inayat Bashir ^a   Mallikarjuna Setty, C ^b  

^a GOVERNMENT COLLEGE OF PHARMACY   (India)

^b Vishnu Institute of Pharmaceutical Education and Research   (India)

Author keywords

In vivo studies; Nanoemulsion; Penetration enhancers; Transdermal delivery

Indexed keywords

MUS; RATTUS;

EID: 84866550094     PISSN: None     EISSN: 18423582     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. R. Clarke, M.C. Liu, K.B Bouker, Oncogene 22, 7316 (2003).
2. V.C. Jordan, C.S. Murphy, Endocr. Rev 11, 49 (1990).
3. B.J. Furr, V.C. Jordan, Pharm. Ther 25, 127(1984).
4. M. Morrow, V.C. Jordan. Risk factors and the prevention of breast cancer with tamoxifen. In Cancer Surveys: Breast cancer, ed. JT Papademitrio, I Fentiman, Imperial Res. Fund. London: Cold Spring Harbor Lab. Press 18, 211 (1993).
5. V. C. Jordan, Annu Rev Pharmacol Toxicol 35, 195(1995).
6. I Brigger, P.Chaminade, V. Marsaud, M. Appel, M. Besnard, R. Gurny, M. Renoir, P. Couvreur, Int J Pharm 214, 37 (2001).
7. R.H Guy, Pharm.Res 13,1765 (1996).
8. D. W. Osborne, A. J. Ward and K. J. Neil, J. Pharm. Phamacol. 43 450 (1991).
9. M. Trotta, F. Pattarino and M. R. Gasco, Pharm. Acta. Helv. 71, 135 (1996).
10. I. B. Pathan, C.M. Setty, International Journal of PharmTech Research 3, 287(2011).
11. S. Shafiq, S. Faiyaz, T. Sushma, J. A. Farhan, R. K. Khar and M. Ali, Eur. J. Pharm. Biopharm 66, 227(2007).
12. P.C. Hiemenz, R. Rajgopalan, In: Principles of colloidal and surface chemistry, 3rd edition, Marcel Dekker, New York 389(1997).
13. T.R.K Kommuru, B. Gurley, M.A. Khan, I.K Reddy, Int J Pharm 212,233 (2001).
14. P. P Constantinides, Pharm Res 12,1561(1995).
15. M.J Lawrence, G.D Rees, Adv Drug Deliv Rev 45, 89(2000).
16. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara, Masuda K, J Control Rel 81,65(2002).
17. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara, K. Masuda, J Control Rel 81,75 (2002).
18. N Dixit, K. Kohli, S. Baboota, PDA J. Pharm. Sci. Technol 62, 46 (2008).
19. S. Khandavilli, R. Panchagnula, J. Invest. Dermatol 127, 154(2007).
20. Shevachman, M.; Garti, N.; Shani, A.; Sintov, A.C. Drug Dev. Ind. Pharm. 34, 403. (2008).
21. S. Baboota, A. Al-Azaki, K. Kohli, J. Ali, N. Dixit, F. Shakeel, PDA J. Pharm Sci. Technol 61, 276(2007).
22. G. Kantarci, I. Ozguney, H.Y. Karasulu, S. Arzi, T. Guneri, AAPS Pharm. Sci. Tech. 8, E 91(2007).
23. Y.B. Huang, Y.H. Lin, T.M. Lu, R.J. Wang, Y.H. Tsai, P.C. Wu, Int. J. Pharm 349, 206(2008).
24. V.B. Junyaprasert, P. Boonsaner, S. Leatwimonlak, P. Boonme, Drug Dev. Ind. Pharm 33, 874 (2007)
25. V.B. Junyaprasert, P. Boonme, S. Songkro, K. Krauel, T. Rades, J. Pharm. Pharm. Sci 10, 288 (2007).
26. M.A. Kamal, N. Iimura, T. Nabekura, S. Kitagawa, Chem. Pharm. Bull 55, 368 (2007).
27. P.J. Lee, R. Langer, V.P. Shastri, Pharm. Res 20, 264(2003).
28. J.S Yuan, M. Ansari, M. Samaan, E.J.Acosta, Int. J. Pharm 349, 130(2008).
29. Y. Yuan, S.M Li, F.K Mo, D.F Zhong, Int. J. Pharm 321,117(2006).
30. B. Biruss, H Kählig, C.Valenta, Int. J. Pharm, 328, 142 (2007).
31. M. Shevachman, N. Garti, A. Shani, A.C. Sintov, Drug Dev. Ind. Pharm 34, 403(2008).
32. F. Shakeel, S. Baboota, A. Ahuja, J. Ali, M. Aqil, S. Shafiq, AAPS Pharm. Sci. Tech. 8, E 104(2007).
33. K.W. Ambade, S.L. Jadhav, M.N. Gambhire, S.D. Kurmi, V.J. Kadam, K.R. Jadhav, Curr. Drug Deliv 5, 32(2008).
34. X. Zhao, J.P. Liu, X Zhang, Y. Li, Int. J. Pharm 327, 58(2006).
35. D. Paolino, C.A. Ventura, S. Nisticò,G. Puglisi, M. Fresta, Int. J. Pharm 21,244(2002)
36. A.C. Sintov, S. Botner,. Int. J. Pharm, 311, 55 (2006).
37. B Prapaporn, K. Karen, G. Anja, R. Thomas, B. J. Varaporn, AAPS Pharm- SciTech 7(2), E1(2006).
38. I.B. Pathan, C. M. Setty, V.R.M. Gupta, Acta Pharmaceutica Sciencia 50:219(2008).
39. A. Namdeo, N.K. Jain. J Control Release 82, 223(2002).
40. S. Mutalik, N.Udupa, J Pharm Sci 93,1577(2004).
41. F. Kuo, T.A. Wilson, L. Kifle, T. Panagiotou, I. Gruverman, J.B. Tagne, et al, Exp Ther Oncology 6, 129(2007).
42. J.H Draize, G. Woodward, H.O Calvery, J Pharmacol Exp Ther 82,77(1944).
43. Amit Bhatia., Rajiv Kumar and Om Prakash Katare, J Pharm Pharmaceut Sci 7(2), 252 (2004).
44. M. J. Lawrence and G. D. Rees, Adv. Drug Deliv. Rev 45, 89(2000).
45. W. Warisnoicharoen, A. B. Lansley and M. J. Lawrence, AAPS PharmSci 2, (2000).
46. S. Shafiq, S. Faiyaz, T. Sushma, J. A. Farhan, R. K. Khar and M. Ali, J. Biomed. Nanotechnol 3, 28(2007).
47. S. Shafiq, S. Faiyaz, T. Sushma, J. A. Farhan, R. K. Khar and M. Ali, Eur. J. Pharm. Biopharm 66, 227(2007).
48. D. Thacrodi, R.K. Panduranga, Int. J. Pharm 111, 235(1994).
49. T. Kotyla, F. Kuo, V. Moolchandani, T. Wilson, R. Nicolosi, Int. J. Pharm 347,144(2008).
50. R. Sinha, G.J. Kim, S. Nie, D.M. Shin, Mol. Cancer. Ther 5, 1909(2006).
51. P.A. Jarzyna, T. Skajaa, A. Gianella, D.P. Cormode, D.D. Samber S.D. Dickson, et al, 30, 6947(2009).
52. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, J Control Release 65, 271(2000).
53. J.M. Koziara, T.R. Whisman, M.T. Tseng, R.J. Mumper, Journal of Controlled Release 112,12(2006).
54. G.F. Dawson, G.W. Halbert, Pharmaceutical Research 17, 142(2000).
55. H.M. Redhead, S.S. Davis, L. Illum, J. Control. Release 70, 353(2001).